Qorvo® Expands Presence in Defense Market with Veteran-Owned U.S. Distributor
Sep 18, 2017 12:01 pm UTC| Business
GREENSBORO, N.C., Sept. 18, 2017 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today announced that it has entered into a channel partnership with Veterans Trading...
Sep 18, 2017 12:01 pm UTC| Business
Preclinical Research Demonstrating a Direct Relationship Between Misfolded Light Chain Toxicity and NT-proBNP ProductionClinical Outcomes Research Showing a Correlation between NT-proBNP Response and Health-related Quality...
Achaogen Adds Liz Bhatt as Chief Business Officer
Sep 18, 2017 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2017 -- Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections,...
Sep 18, 2017 12:01 pm UTC| Business
PLYMOUTH MEETING, Pa., Sept. 18, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the Korean Ministry of Food and Drug Safety approved the initiation of a study to evaluate GLS-5300, Inovio’s...
HCI Group Insurance Subsidiaries Issue Loss Estimates from Hurricane Irma
Sep 18, 2017 12:01 pm UTC| Business
TAMPA, Fla., Sept. 18, 2017 -- HCI Group, Inc. (NYSE:HCI) has issued initial loss estimates from Hurricane Irma, which made landfall in the Florida Keys last week before making a second landfall in the southwest coast...
CymaBay Therapeutics to Present at Two Investor Conferences
Sep 18, 2017 12:01 pm UTC| Business
NEWARK, Calif., Sept. 18, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need,...
Gemphire to Present at Cantor Fitzgerald Global Healthcare Conference on September 26 in New York
Sep 18, 2017 12:01 pm UTC| Business
LIVONIA, Mich., Sept. 18, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...